Use of amnion chorion and umbilical cord grafts in conjunction with penile implant procedures

Abstract

Biologics have increased in popularity lately as a novel and exciting new therapy for men with a spectrum of sexual dysfunction ailments-ranging from erectile dysfunction, Peyronie's disease, and ejaculatory disorders. In this series, sequential patients were analyzed who received biologic materials at the time of their penile implant surgery, with various metrics assessed. The information gathered includes recovery time, need for postoperative analgesics, and satisfaction with the final outcome. In this study, early metrics appear to point to improved outcomes in select criteria. Further study will need to address whether treatment with biologics has broader appeal, but in the penile implant patient, the surgery seems to be augmented with the placement of biologic material into the surgical wound.